IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v17y2020i9p3196-d353871.html
   My bibliography  Save this article

The Italian External Quality Assessment Program for Cystic Fibrosis Sweat Chloride Test: Does Active Participation Improve the Quality?

Author

Listed:
  • Marco Salvatore

    (Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, National Center Rare Diseases, 00161 Rome, Italy)

  • Annalisa Amato

    (Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, National Center Rare Diseases, 00161 Rome, Italy)

  • Giovanna Floridia

    (Unità di Bioetica, Istituto Superiore di Sanità, 00161 Roma, Italia)

  • Federica Censi

    (Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, National Center Rare Diseases, 00161 Rome, Italy)

  • Gianluca Ferrari

    (Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, National Center Rare Diseases, 00161 Rome, Italy)

  • Fabrizio Tosto

    (Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, National Center Rare Diseases, 00161 Rome, Italy)

  • Rita Padoan

    (Centro di Supporto Fibrosi Cistica, Dipartimento Pediatrico, Università di Brescia, ASST Spedali Civili, 25123 Brescia, Italia)

  • Valeria Raia

    (Centro Regionale Fibrosi Cistica, Unità di Pediatria, Dipartimento di Scienze Mediche Traslazionali, Università degli Studi di Napoli, Federico II, 80145 Napoli, Italia)

  • Natalia Cirilli

    (Centro di Riferimento Fibrosi Cistica, Dipartimento Materno Infantile, AOU Ospedali Riuniti, 60121 Ancona, Italia)

  • Giuseppe Castaldo

    (Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II; CEINGE-Biotecnologie avanzate, scarl, 80131 Napoli, Italia)

  • Ettore Capoluongo

    (Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli Federico II; CEINGE-Biotecnologie avanzate, scarl, 80131 Napoli, Italia)

  • Ubaldo Caruso

    (LABSIEM—Laboratorio per lo Studio degli Errori Congeniti del Metabolismo, Università degli Studi di Genova—DINOGMI, 16132 Genova, Italia)

  • Carlo Corbetta

    (SC Laboratorio di Riferimento Regionale per lo Screening Neonatale—Regione Lombardia, ASST Fatebenefratelli Sacco, 20157 Milano, Italia)

  • Domenica Taruscio

    (Undiagnosed Rare Diseases Interdepartmental Unit, Istituto Superiore di Sanità, National Center Rare Diseases, 00161 Rome, Italy)

Abstract

(1) Background: Diagnostic testing for cystic fibrosis (CF) is based on a sweat chloride test (SCT) considering the appropriate signs and symptoms of the disease and results of a gene mutation analysis. In 2014, the Istituto Superiore di Sanità (ISS) established a pilot Italian external quality assessment program for CF SCT (Italian EQA-SCT), which is now a third party service carried out by the ISS. (2) Methods: The ongoing scheme is prospective, enrollment is voluntary, and the payment of a fee is required. Results are shared through a dedicated web-facility. Assessment covers the analysis, interpretation, and reporting of results. (3) Results: Thirteen, fifteen, sixteen, and fifteen different laboratories, respectively, participated from 2015 to 2016 and from 2018 to 2019 in the Italian EQA-SCT scheme. Eleven different laboratories participated each year in all four rounds of the Italian EQA-SCT. (4) Conclusions: The overall results obtained from the laboratories participating constantly clearly show that their qualitative and quantitative performance improved significantly. This is due to the opportunity—after receiving the EQA results—to constantly review their performance and address any inconsistencies. We firmly believe that participation in the EQA program will improve the quality of participating laboratories and that EQA participation should become mandatory as a fundamental requirement for laboratory accreditation.

Suggested Citation

  • Marco Salvatore & Annalisa Amato & Giovanna Floridia & Federica Censi & Gianluca Ferrari & Fabrizio Tosto & Rita Padoan & Valeria Raia & Natalia Cirilli & Giuseppe Castaldo & Ettore Capoluongo & Ubald, 2020. "The Italian External Quality Assessment Program for Cystic Fibrosis Sweat Chloride Test: Does Active Participation Improve the Quality?," IJERPH, MDPI, vol. 17(9), pages 1-12, May.
  • Handle: RePEc:gam:jijerp:v:17:y:2020:i:9:p:3196-:d:353871
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/17/9/3196/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/17/9/3196/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:17:y:2020:i:9:p:3196-:d:353871. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.